Both metformin and MK2 inhibitors work by targeting the liver, but the way they each work is different and this, the researchers say, is key as it means that the benefits of MK2 inhibitors can build upon the benefits of metformin.
Read more
Diabetes UK – New drug cocktail could prevent obese patients and others at risk of Type 2